Ramsay Health Care Limited share price up 2% on global supply chain JV

The Ramsay Health Care Limited (ASX:RHC) share price is up 2% after announcing it is setting up a global supply chain joint venture.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is up 2% after announcing that it is entering into a global supply chain joint venture.

Its partner is called Ascension, the largest private, tax-exempt, non-governmental health organisation in the United States.

Ramsay said that the joint venture will combine the purchasing power of the St. Louis-based Ascension, the world's largest Catholic health system and Ramsay Health Care. Of course, readers will know Ramsay as one of the world's largest private hospital operators that operates over 230 facilities in six countries across four continents.

The joint venture company will be owned equally by Ramsay and Ascension. It will start by identifying an initial group of product categories to achieve procurement savings.

Ramsay also said that in time it will include more product categories and will explore broader business development opportunities that are expected to generate further commercial benefits for the two entities.

This new joint venture will apparently be undertaken with minimal cost to each group and the initial savings will be slightly earnings per share (EPS) accretive to Ramsay in the short-term.

Foolish takeaway

Ramsay didn't flag this as a material announcement. To start off with, it won't be – but it could turn into something quite material if it develops into a major player for product procurement, particularly in the huge US market.

I like Ramsay as an investment idea due to the quality of the business and long-term ageing of the population. This doesn't change its figures much in the near future, but at 20x FY19's estimated earnings I think it represents attractive long-term value.

Motley Fool contributor Tristan Harrison owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists working in the laboratory and examining results.
Healthcare Shares

Why did the CSL share price go backwards in 2024?

CSL shares closed out 2024 in the red. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which All Ords ASX healthcare stock just surged 11% on FDA news

Investors are sending the ASX healthcare stock soaring on Monday.

Read more »

Healthcare Shares

Guess which ASX small cap stock is jumping on 'significant milestone'

This stock is ending the week in style. Let's see what is giving its shares a boost today.

Read more »

Healthcare Shares

Are CSL and this ASX 200 healthcare stock buys in January?

Is now a good time to pick up these shares? Let's see what analysts are saying.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Communication Shares

2 ASX shares expected to report strong earnings this quarter

Analysts expect a strong set of upcoming numbers for these ASX heavyweights

Read more »

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »